Richard E. Chaisson, M.D., Chair of the Tuberculosis Transformative Science Group for the AIDS Clinical Trials Group (ACTG) Network, is Professor of Medicine, Epidemiology and International Health at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health in Baltimore, MD, USA. From 1988-1998 he was director of the Johns Hopkins AIDS Service, and he co-founded with Richard Moore the Johns Hopkins HIV Clinic Cohort, an observational cohort study that has made seminal contributions to understanding the outcomes of HIV disease and its treatment.
Dr. Richard E. Chaisson
Dr. Chaisson is founder and director of the Johns Hopkins Center for Tuberculosis Research, a multidisciplinary institute dedicated to the study of TB from bench to bedside to community. His research interests focus on tuberculosis and HIV infection, including global epidemiology, clinical trials, diagnostics, and public health interventions. He is also principal investigator and director of the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), an international research consortium funded by the Bill and Melinda Gates Foundation to assess the impact of novel strategies for controlling HIV-related TB at the population level, including active case finding and widespread use of TB preventive therapy. He maintains active collaborative research and training programs in Brazil, South Africa, Malawi, Lesotho, and India. Most recently he assumed leadership of the Johns Hopkins Center for AIDS Research (CFAR), re-establishing and revitalizing a trans-disciplinary program to catalyze innovative HIV research at Hopkins, with a special focus on combatting the Baltimore epidemic. He has published over 400 scientific papers and book chapters.